Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.45 USD | -0.32% | -5.78% | -12.18% |
10/05 | Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating | MT |
09/05 | Xenon Pharmaceuticals Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.18% | 306.23Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
-12.64% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-8.58% | 1.68TCr | |
+37.41% | 1.25TCr | |
-23.95% | 808.97Cr |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- Guggenheim Adjusts Price Target on Xenon Pharmaceuticals to $49 From $53, Maintains Buy Rating